Geron
Geron Corporation
Alias
United States of America
Telomerase inhibitor development
Cancer therapeutics
Biopharmaceutical research
Business Development
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
Loading...
Loading the relationship graph...
1 entries
| Date | Description |
| 2022 |
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones |
2026-09-21 18:13 (Model: ggml-org/gpt-oss-20b )